Devanjan Sikder

3.5k total citations
34 papers, 2.0k citations indexed

About

Devanjan Sikder is a scholar working on Molecular Biology, Oncology and Endocrine and Autonomic Systems. According to data from OpenAlex, Devanjan Sikder has authored 34 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Endocrine and Autonomic Systems. Recurrent topics in Devanjan Sikder's work include Cancer therapeutics and mechanisms (8 papers), Sleep and Wakefulness Research (6 papers) and CAR-T cell therapy research (4 papers). Devanjan Sikder is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Sleep and Wakefulness Research (6 papers) and CAR-T cell therapy research (4 papers). Devanjan Sikder collaborates with scholars based in United States, India and France. Devanjan Sikder's co-authors include Thomas Kodadek, Dyan Sellayah, Preeti Bharaj, Arvind Kumar, Eric J. Nestler, Guanghua Xiao, William Renthal, Valakunja Nagaraja, Kip Nalley and Matthew B. Wilkinson and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Devanjan Sikder

34 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devanjan Sikder United States 21 1.1k 339 324 282 277 34 2.0k
Jamie M. Kramer Canada 24 1.1k 1.0× 333 1.0× 294 0.9× 176 0.6× 224 0.8× 37 2.2k
Christos G. Gkogkas Canada 25 1.7k 1.6× 520 1.5× 331 1.0× 195 0.7× 359 1.3× 50 2.5k
Elizabeth A. Pollina United States 13 1.7k 1.5× 196 0.6× 457 1.4× 163 0.6× 116 0.4× 15 2.7k
Sara M. Lindsay United States 21 878 0.8× 910 2.7× 244 0.8× 264 0.9× 760 2.7× 34 2.5k
Mónica Bayés Spain 29 1.1k 1.0× 464 1.4× 148 0.5× 248 0.9× 532 1.9× 55 2.6k
Weiwei Zhong United States 25 908 0.8× 245 0.7× 117 0.4× 126 0.4× 202 0.7× 77 1.9k
Susan Reid United States 9 569 0.5× 716 2.1× 151 0.5× 125 0.4× 179 0.6× 14 1.5k
Amy W. Lasek United States 28 812 0.7× 833 2.5× 178 0.5× 114 0.4× 163 0.6× 69 1.9k
Vladimir V. Senatorov United States 23 1.0k 0.9× 969 2.9× 237 0.7× 91 0.3× 282 1.0× 53 2.4k

Countries citing papers authored by Devanjan Sikder

Since Specialization
Citations

This map shows the geographic impact of Devanjan Sikder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devanjan Sikder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devanjan Sikder more than expected).

Fields of papers citing papers by Devanjan Sikder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devanjan Sikder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devanjan Sikder. The network helps show where Devanjan Sikder may publish in the future.

Co-authorship network of co-authors of Devanjan Sikder

This figure shows the co-authorship network connecting the top 25 collaborators of Devanjan Sikder. A scholar is included among the top collaborators of Devanjan Sikder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devanjan Sikder. Devanjan Sikder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palomba, M. Lia, Isabelle Rivière, Devanjan Sikder, et al.. (2023). A Phase I Study of CD19‐targeted 19(T2)28z1xx CAR T Cells in Adult Patients with Relapsed or Refractory Diffuse Large B‐cell Lymphoma. Hematological Oncology. 41(S2). 527–528. 1 indexed citations
2.
Sellayah, Dyan, Preeti Bharaj, & Devanjan Sikder. (2012). Orexin Is Required for Brown Adipose Tissue Development, Differentiation, and Function. Cell Metabolism. 16(4). 550–550. 9 indexed citations
3.
Sellayah, Dyan & Devanjan Sikder. (2012). Orexin receptor-1 mediates brown fat developmental differentiation. Adipocyte. 1(1). 58–63. 30 indexed citations
4.
Sellayah, Dyan, Preeti Bharaj, & Devanjan Sikder. (2011). Orexin Is Required for Brown Adipose Tissue Development, Differentiation, and Function. Cell Metabolism. 14(4). 478–490. 204 indexed citations
5.
Renthal, William, Arvind Kumar, Guanghua Xiao, et al.. (2009). Genome-wide Analysis of Chromatin Regulation by Cocaine Reveals a Role for Sirtuins. Neuron. 62(3). 335–348. 300 indexed citations
6.
Singh, Sarvjeet, Devanjan Sikder, Michael J. Birrer, et al.. (2009). Calcineurin Activates Cytoglobin Transcription in Hypoxic Myocytes. Journal of Biological Chemistry. 284(16). 10409–10421. 30 indexed citations
7.
Ferdous, Anwarul, et al.. (2008). Phosphorylation of the Gal4DNA-binding domain is essential for activator mono-ubiquitylation and efficient promoter occupancy. Molecular BioSystems. 4(11). 1116–1125. 7 indexed citations
8.
Renthal, William, Carly F. Hale, Makoto Taniguchi, et al.. (2008). Cocaine Regulates MEF2 to Control Synaptic and Behavioral Plasticity. Neuron. 59(4). 621–633. 218 indexed citations
9.
Xiao, Xiangshu, Peng Yu, Hyun‐Suk Lim, Devanjan Sikder, & Thomas Kodadek. (2007). A Cell‐Permeable Synthetic Transcription Factor Mimic. Angewandte Chemie International Edition. 46(16). 2865–2868. 63 indexed citations
10.
Kodadek, Thomas, Devanjan Sikder, & Kip Nalley. (2006). Keeping Transcriptional Activators under Control. Cell. 127(2). 261–264. 93 indexed citations
11.
Sikder, Devanjan, Stephen Albert Johnston, & Thomas Kodadek. (2006). Widespread, but Non-identical, Association of Proteasomal 19 and 20 S Proteins with Yeast Chromatin. Journal of Biological Chemistry. 281(37). 27346–27355. 56 indexed citations
12.
Ferdous, Anwarul, Devanjan Sikder, Thomas G. Gillette, et al.. (2006). The role of the proteasomal ATPases and activator monoubiquitylation in regulating Gal4 binding to promoters. Genes & Development. 21(1). 112–123. 56 indexed citations
13.
Sikder, Devanjan & Thomas Kodadek. (2005). Genomic studies of transcription factor–DNA interactions. Current Opinion in Chemical Biology. 9(1). 38–45. 48 indexed citations
14.
Lovett‐Racke, Amy E., A. Rocchini, Judy Choy, et al.. (2004). Silencing T-bet Defines a Critical Role in the Differentiation of Autoreactive T Lymphocytes. Immunity. 21(5). 719–731. 153 indexed citations
15.
Nagaraja, Valakunja, Devanjan Sikder, & Paras Jain. (2002). DNA Topoisomerase I from Mycobacteria - A Potential Drug Target. Current Pharmaceutical Design. 8(22). 1995–2007. 15 indexed citations
16.
Sikder, Devanjan & Valakunja Nagaraja. (2001). A novel bipartite mode of binding of M. smegmatis topoisomerase I to its recognition sequence. Journal of Molecular Biology. 312(2). 347–357. 17 indexed citations
17.
Sikder, Devanjan, et al.. (2001). Functional cooperation between topoisomerase I and single strand DNA-binding protein. Journal of Molecular Biology. 306(4). 669–679. 27 indexed citations
18.
Basak, Shashwati, et al.. (2000). Inhibition of Mycobacterium smegmatis topoisomerase I by specific oligonucleotides. FEBS Letters. 486(2). 126–130. 8 indexed citations
19.
Bagui, Tapan, et al.. (1998). DNA Topoisomerase I from Mycobacterium smegmatis. Journal of Biological Chemistry. 273(22). 13925–13932. 57 indexed citations
20.
Sikder, Devanjan, et al.. (1998). Sequence specific interaction of Mycobacterium smegmatis topoisomerase I with duplex DNA. Nucleic Acids Research. 26(7). 1668–1674. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamie M. Kramer Breakdown of academic impact, for papers by Christos G. Gkogkas Breakdown of academic impact, for papers by Elizabeth A. Pollina Breakdown of academic impact, for papers by Sara M. Lindsay Breakdown of academic impact, for papers by Mónica Bayés Breakdown of academic impact, for papers by Weiwei Zhong Breakdown of academic impact, for papers by Susan Reid Breakdown of academic impact, for papers by Amy W. Lasek Breakdown of academic impact, for papers by Vladimir V. Senatorov
Rankless by CCL
2026